{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:45:36Z","timestamp":1777563936140,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Gynecology and Obstetrics, RWTH Aachen University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jad.2017.01.019","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T12:00:53Z","timestamp":1485000053000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Sertraline in pregnancy \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood"],"prefix":"10.1016","volume":"212","author":[{"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamme W.","family":"Goecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.01.019_bib1","article-title":"James G. Wilson's six principles of teratology, embryo Project Encyclopedia ed","author":"Aston","year":"2014","journal-title":"Embryo Proj. Encycl."},{"issue":"9665","key":"10.1016\/j.jad.2017.01.019_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jad.2017.01.019_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.psy.0000244025.20549.bd","article-title":"Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care","volume":"68","author":"Dayan","year":"2006","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.jad.2017.01.019_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2008.07.002","article-title":"Prenatal depression restricts fetal growth","volume":"85","author":"Diego","year":"2009","journal-title":"Early Hum. Dev."},{"issue":"5","key":"10.1016\/j.jad.2017.01.019_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/138920111795470877","article-title":"Drug transport across the placenta","volume":"12","author":"Eshkoli","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"7","key":"10.1016\/j.jad.2017.01.019_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.jad.2017.01.019_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/JCP.0b013e31818d2048","article-title":"Pharmacokinetics of sertraline across pregnancy and postpartum","volume":"28","author":"Freeman","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2017.01.019_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40360-015-0033-x","article-title":"Use of prescription medicines in Australian women of child-bearing age","volume":"16","author":"Gadzhanova","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.jad.2017.01.019_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(24)39087-1","article-title":"Placental transporters relevant to drug distribution across the maternal-fetal interface","volume":"294","author":"Ganapathy","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1092852900027449","article-title":"On categorizing gestational, birth, and neonatal complications Following late pregnancy exposure to antidepressants: the Prenatal antidepressant exposure syndrome","volume":"15","author":"Gentile","year":"2010","journal-title":"CNS Spectr."},{"issue":"1\u20132","key":"10.1016\/j.jad.2017.01.019_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.02.125","article-title":"Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review","volume":"128","author":"Gentile","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.jad.2017.01.019_bib12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425255.2012.699041","article-title":"Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier","volume":"8","author":"Giaginis","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"10","key":"10.1016\/j.jad.2017.01.019_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.01.019_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jad.2017.01.019_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2017.01.019_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S0033291709990894","article-title":"Maternal psychological distress and fetal growth trajectories: the generation R study","volume":"40","author":"Henrichs","year":"2010","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.jad.2017.01.019_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1016\/j.jad.2017.01.019_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2017.01.019_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jad.2017.01.019_bib20","first-page":"B4916","article-title":"Exposure to antidepressants during pregnancy--prevalences and outcomes","volume":"61","author":"Jimenez-Solem","year":"2014","journal-title":"Dan. Med. J."},{"issue":"12","key":"10.1016\/j.jad.2017.01.019_bib21","doi-asserted-by":"crossref","first-page":"e0165122","DOI":"10.1371\/journal.pone.0165122","article-title":"Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark","volume":"11","author":"Jordan","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2017.01.019_bib22","first-page":"1221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"Kallen","year":"2013"},{"issue":"4","key":"10.1016\/j.jad.2017.01.019_bib23","first-page":"171","article-title":"Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population","volume":"15","author":"Kaplan","year":"2012","journal-title":"J. Ment. Health Policy Econ."},{"issue":"7","key":"10.1016\/j.jad.2017.01.019_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0090-9556(24)15222-1","article-title":"Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro","volume":"27","author":"Kobayashi","year":"1999","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"7","key":"10.1016\/j.jad.2017.01.019_bib25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2017.01.019_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","article-title":"Antidepressants in amniotic fluid: another route of fetal exposure","volume":"163","author":"Loughhead","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2017.01.019_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1124\/dmd.111.038166","article-title":"ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition","volume":"39","author":"Mason","year":"2011","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/sper.2001.24901","article-title":"Antidepressants during pregnancy and lactation: defining exposure and treatment issues","volume":"25","author":"Newport","year":"2001","journal-title":"Semin. Perinatol."},{"issue":"11","key":"10.1016\/j.jad.2017.01.019_bib29","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/JCP.0000000000000308","article-title":"Suicide attempt during late pregnancy with quetiapine: nonfatal outcome despite severe intoxication","volume":"35","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2017.01.019_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000088","article-title":"Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood","volume":"30","author":"Paulzen","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2017.01.019_bib32","first-page":"S354","article-title":"Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation","volume":"57","author":"Ram","year":"2015","journal-title":"Indian J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib33","first-page":"329","article-title":"A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate","volume":"7","author":"Rampono","year":"2004","journal-title":"Int. J. Neuropsychopharmacol. \/ Off. Sci. J. Coll. Int. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2017.01.019_bib35","doi-asserted-by":"crossref","first-page":"h3190","DOI":"10.1136\/bmj.h3190","article-title":"Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports","volume":"351","author":"Reefhuis","year":"2015","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/j.jad.2017.01.019_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13318-010-0021-x","article-title":"Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term","volume":"35","author":"Reimers","year":"2011","journal-title":"Eur. J. Drug Metab. Pharm."},{"issue":"5","key":"10.1016\/j.jad.2017.01.019_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","article-title":"Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression","volume":"19","author":"Reis","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.jad.2017.01.019_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jad.2011.07.022","article-title":"Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose","volume":"135","author":"Roca","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2017.01.019_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1741-4520.2010.00308.x","article-title":"Drug safety in pregnancy: utopia or achievable prospect? Risk information, Risk research and advocacy in Teratology information Services","volume":"51","author":"Schaefer","year":"2011","journal-title":"Congenit. Anom."},{"issue":"4","key":"10.1016\/j.jad.2017.01.019_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04332.x","article-title":"Prescribing without evidence - pregnancy","volume":"74","author":"Thomas","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jad.2017.01.019_bib41","first-page":"e7","article-title":"Are major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control study","volume":"33","author":"Uguz","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.01.019_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1248\/bpb.31.231","article-title":"Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jad.2017.01.019_bib43","series-title":"Environment and Birth Defects","author":"Wilson","year":"1973"},{"issue":"3","key":"10.1016\/j.jad.2017.01.019_bib44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2125.1999.00023.x","article-title":"Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes","volume":"48","author":"Xu","year":"1999","journal-title":"Br. J. Clin. Pharm."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716319358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716319358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:15:41Z","timestamp":1759022141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032716319358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":44,"alternative-id":["S0165032716319358"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.01.019","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sertraline in pregnancy \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}